Pharma & Healthcare
Growth & Differentiation Factor 8
- Types
- ACE-2494 · ACE-2798 · BMS-986089
- Applications
- Fibrosis · Sickle Cell Disease · Myelofibrosis
5 editions19 December 2025
Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions2 January 2026
Pharma & Healthcare
5 editions29 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions27 December 2025
Pharma & Healthcare
5 editions23 December 2025
Pharma & Healthcare
5 editions26 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions27 December 2025
Pharma & Healthcare
Hyperkalemia is a diseases in which levels of potassium are higher than normal level (3.5 and 5.0 mmol/L) in blood serum. Kidneys are responsible for managing potassium balance in the body by regulating its excretion as well as its intake. A person is prone to develop hyperkalemia when the consumption of potassium exceeds that of kidneys’ potential to excrete it. The right amount of potassium and sodium in the body play a vital role in normal functioning of the myocardium.
5 editions29 December 2025